Detalhe da pesquisa
1.
Phase 2, open-label, 1:1 randomized controlled trial exploring the efficacy of EMD 1201081 in combination with cetuximab in second-line cetuximab-naïve patients with recurrent or metastatic squamous cell carcinoma of the head and neck (R/M SCCHN).
Invest New Drugs
; 32(6): 1278-84, 2014 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24894651
2.
Serial comprehensive geriatric assessment in elderly head and neck cancer patients undergoing curative radiotherapy identifies evolution of multidimensional health problems and is indicative of quality of life.
Eur J Cancer Care (Engl)
; 23(3): 401-12, 2014 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-24467393
3.
Sunitinib for metastatic renal cell cancer patients: observational study highlighting the risk of important drug-drug interactions.
J Clin Pharm Ther
; 39(3): 259-65, 2014 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-24417304
4.
A phase Ib, open-label study to assess the safety of continuous oral treatment with afatinib in combination with two chemotherapy regimens: cisplatin plus paclitaxel and cisplatin plus 5-fluorouracil, in patients with advanced solid tumors.
Ann Oncol
; 24(5): 1392-400, 2013 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-23293114
5.
A patient with acquired factor X deficiency and metastatic transitional cell carcinoma of the bladder: is there a link between metastasis and factor deficiency in solid tumors?
Ann Hematol
; 97(3): 545-546, 2018 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-29130135
6.
Avelumab or talazoparib in combination with binimetinib in metastatic pancreatic ductal adenocarcinoma: dose-finding results from phase Ib of the JAVELIN PARP MEKi trial.
ESMO Open
; 8(4): 101584, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37379764
7.
Phase II study of everolimus in patients with locally advanced or metastatic transitional cell carcinoma of the urothelial tract: clinical activity, molecular response, and biomarkers.
Ann Oncol
; 23(10): 2663-2670, 2012 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-22473592
8.
Changes in anticancer treatment plans in patients with solid cancer hospitalized with COVID-19: analysis of the nationwide BSMO-COVID registry providing lessons for the future.
ESMO Open
; 7(6): 100610, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36356416
9.
Isatuximab plus atezolizumab in patients with advanced solid tumors: results from a phase I/II, open-label, multicenter study.
ESMO Open
; 7(5): 100562, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-35987165
10.
PRECISION: the Belgian molecular profiling program of metastatic cancer for clinical decision and treatment assignment.
ESMO Open
; 7(4): 100524, 2022 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35970014
11.
Evaluation of EGFR gene copy number as a predictive biomarker for the efficacy of cetuximab in combination with chemotherapy in the first-line treatment of recurrent and/or metastatic squamous cell carcinoma of the head and neck: EXTREME study.
Ann Oncol
; 22(5): 1078-1087, 2011 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-21048039
12.
Metabolic tumour volume. Prognostic value in locally advanced squamous cell carcinoma of the head and neck.
Nuklearmedizin
; 50(4): 141-6, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21594304
13.
A randomized phase II study comparing the efficacy and safety of the glyco-optimized anti-EGFR antibody tomuzotuximab against cetuximab in patients with recurrent and/or metastatic squamous cell cancer of the head and neck - the RESGEX study.
ESMO Open
; 6(5): 100242, 2021 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-34482179
14.
Quality of life of patients receiving platinum-based chemotherapy plus cetuximab first line for recurrent and/or metastatic squamous cell carcinoma of the head and neck.
Ann Oncol
; 21(10): 1967-1973, 2010 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-20335368
15.
Necrotizing myopathy as a paraneoplastic syndrome associated with renal cell carcinoma.
Acta Clin Belg
; 70(1): 61-4, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25268468
16.
CD70: An emerging target in cancer immunotherapy.
Pharmacol Ther
; 155: 1-10, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26213107
17.
Progression of renal failure in patients with compromised renal function is not always present: evaluation of underlying disease.
Clin Nephrol
; 54(1): 1-10, 2000 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-10939750
18.
Prospective non-interventional multicentre observational trial of first-line anti-cancer treatment in patients with metastatic renal cell cancer in Belgium.
Acta Clin Belg
; 69(5): 335-40, 2014 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-25056491
19.
Nephrotoxicity of anticancer drugs--an underestimated problem?
Acta Clin Belg
; 66(5): 337-45, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-22145268
20.
Cardiovascular toxicity of cancer treatment.
Acta Clin Belg
; 66(4): 260-6, 2011.
Artigo
em Inglês
| MEDLINE | ID: mdl-21938980